Delivery Order SPE2DB25D3202-SPE2DB25FTBAK
- Not listed
- The Defense Logistics Agency awarded a $10,019.57 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens (0.5 ml units). This competitively awarded, firm fixed-price contract will be completed by July 21, 2025, with performance taking place at the vendor's Corporate Office in Conshohocken, Pennsylvania. The award represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,225.77 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $8,703.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $26,079.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $6,383.18 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen pharmaceutical supplies, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract contains no set-aside designation...
- The Defense Logistics Agency awarded a $9,777.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pens with a completion date of July 22, 2025. This is a competitively awarded, non-set-aside contract with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single requisition fulfillment under AmerisourceBergen's existing contract vehicle...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $14,323.06 on August 13, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.81 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a pediatric or small-quantity pharmaceutical procurement supporting federal medical supply needs. The contract was awarded on a competitive basis with no set-aside designation, utilizing AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $10,834.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTBAKDelivery Order
The Defense Logistics Agency awarded a $6,924.92 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with a completion date of July 30, 2025. This non-competitive, firm fixed-price delivery order represents a pediatric or routine pharmaceutical resupply requirement under the company's existing contract vehicle with DLA. The order will be fulfilled from AmerisourceBergen's distribution operations in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary logistics hub for federal medical supply distribution. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive portfolio of medications and medical commodities to support military and veteran healthcare systems. The company's role as a pharmaceutical prime vendor enables it to provide rapid fulfillment of routine medical supply needs, including specialty pharmaceuticals like Mounjaro (used for diabetes and weight management), to military treatment facilities and other federal healthcare customers on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 7/29/25 |